Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1.244
1.161 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
AbbVie Inc
ABBV
|
$263,45 |
+1,4%
|
$465,46 B |
|
|
|
Amgen Inc
AMGN
|
$403,37 |
-1%
|
$217,70 B |
|
|
|
Gilead Sciences, Inc
GILD
|
$144,405 |
-2,1%
|
$179,29 B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$504,085 |
-0,5%
|
$127,94 B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$731,78 |
-0,4%
|
$76,72 B |
|
|
|
Moderna Inc
MRNA
|
$190,305 |
+0,7%
|
$75,51 B |
|
|
|
argenx SE
ARGX
|
€815,4 |
-3,1%
|
$57,85 B |
|
|
|
CSL Ltd
CSL
|
AU$175,35 |
-1,6%
|
$58,37 B |
|
|
|
Natera Inc
NTRA
|
$408,15 |
-0,1%
|
$58,46 B |
1.156 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita